{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T01:36:17Z","timestamp":1783820177380,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04227-6","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T02:06:54Z","timestamp":1747966014000},"page":"456-465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of peripheral neuropathy with dementia in type 2 diabetes: a 5-year follow-up study using the national health insurance service-national health information database"],"prefix":"10.1007","volume":"89","author":[{"given":"Heung Yong","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko Woon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Ae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Sun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ji","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Seung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"issue":"1","key":"4227_CR1","doi-asserted-by":"publisher","DOI":"10.2174\/1573399817666210309104203","volume":"18","author":"K Nellaiappan","year":"2022","unstructured":"K. Nellaiappan, K. Preeti, D.K. Khatri, S.B. Singh, Diabetic complications: An update on pathobiology and therapeutic strategies. Curr. Diabetes Rev. 18(1), e030821192146 (2022).","journal-title":"Curr. Diabetes Rev."},{"issue":"9","key":"4227_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41574-022-00690-7","volume":"18","author":"D Tomic","year":"2022","unstructured":"D. Tomic, J.E. Shaw, D.J. Magliano, The burden and risks of emerging complications of diabetes mellitus. Nat. Rev. Endocrinol. 18(9), 525\u2013539 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"4227_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4239\/wjd.v13.i4.319","volume":"13","author":"GG Ortiz","year":"2022","unstructured":"G.G. Ortiz, M. Huerta, H.A. Gonzalez-Usigli, E.D. Torres-Sanchez, D.L. Delgado-Lara, F.P. Pacheco-Moises, M.A. Mireles-Ramirez, B.M. Torres-Mendoza, R.I. Moreno-Cih, I.E. Velazquez-Brizuela, Cognitive disorder and dementia in type 2 diabetes mellitus. World J. Diabetes 13(4), 319\u2013337 (2022).","journal-title":"World J. Diabetes"},{"issue":"6","key":"4227_CR4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.4239\/wjd.v14.i6.795","volume":"14","author":"N Ab-Hamid","year":"2023","unstructured":"N. Ab-Hamid, N. Omar, C.A.N. Ismail, I. Long, Diabetes and cognitive decline: Challenges and future direction. World J. Diabetes 14(6), 795\u2013807 (2023).","journal-title":"World J. Diabetes"},{"issue":"11","key":"4227_CR5","doi-asserted-by":"publisher","first-page":"6144","DOI":"10.3390\/ijms23116144","volume":"23","author":"H Ehtewish","year":"2022","unstructured":"H. Ehtewish, A. Arredouani, O. El-Agnaf, Diagnostic, prognostic, and mechanistic biomarkers of diabetes mellitus-associated cognitive decline. Int. J. Mol. Sci. 23(11), 6144 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"4227_CR6","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.ecl.2013.06.001","volume":"42","author":"AI Vinik","year":"2013","unstructured":"A.I. Vinik, M.L. Nevoret, C. Casellini, H. Parson, Diabetic neuropathy. Endocrinol. Metab. Clin. North. Am. 42(4), 747\u2013787 (2013).","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"issue":"1","key":"4227_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41572-019-0097-9","volume":"5","author":"EL Feldman","year":"2019","unstructured":"E.L. Feldman, B.C. Callaghan, R. Pop-Busui, D.W. Zochodne, D.E. Wright, D.L. Bennett, V. Bril, J.W. Russell, V. Viswanathan, Diabetic neuropathy. Nat. Rev. Dis. Prim. 5(1), 42 (2019).","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"1","key":"4227_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4093\/dmj.2020.0216","volume":"45","author":"HY Jin","year":"2021","unstructured":"H.Y. Jin, S.S. Moon, N.A. Calcutt, Lost in translation? Measuring diabetic neuropathy in humans and animals. Diabetes Metab. J. 45(1), 27\u201342 (2021).","journal-title":"Diabetes Metab. J."},{"issue":"20","key":"4227_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026071","volume":"100","author":"YJ Lin","year":"2021","unstructured":"Y.J. Lin, T.W. Kao, W.L. Chen, Relationship between peripheral neuropathy and cognitive performance in the elderly population. Medicine 100(20), e26071 (2021).","journal-title":"Medicine"},{"key":"4227_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13098-015-0045-0","volume":"7","author":"RO Moreira","year":"2015","unstructured":"R.O. Moreira, A.L. Soldera, B. Cury, C. Meireles, R. Kupfer, Is cognitive impairment associated with the presence and severity of peripheral neuropathy in patients with type 2 diabetes mellitus?. Diabetol. Metab. Syndr. 7, 51 (2015).","journal-title":"Diabetol. Metab. Syndr."},{"key":"4227_CR11","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2147\/NDT.S284308","volume":"17","author":"RE Elsharkawy","year":"2021","unstructured":"R.E. Elsharkawy, G.S. Abdel Azim, M.A. Osman, H.M. Maghraby, R.A. Mohamed, E.M. Abdelsalam, E.E. Ebrahem, N.M.A. Seliem, Peripheral polyneuropathy and cognitive impairment in type II diabetes mellitus. Neuropsychiatr. Dis. Treat. 17, 627\u2013635 (2021).","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"4227_CR12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/978-1-4614-0653-2_19","volume":"724","author":"H Umegaki","year":"2012","unstructured":"H. Umegaki, Neurodegeneration in diabetes mellitus. Adv. Exp. Med. Biol. 724, 258\u2013265 (2012).","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1-3","key":"4227_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2010.07.007","volume":"644","author":"M Ohsawa","year":"2010","unstructured":"M. Ohsawa, J. Kamei, RhoA\/Rho kinase signaling in the spinal cord and diabetic painful neuropathy. Eur. J. Pharmacol. 644(1-3), 1\u20134 (2010).","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"4227_CR14","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pain.2010.10.005","volume":"152","author":"M Ohsawa","year":"2011","unstructured":"M. Ohsawa, M. Aasato, S.S. Hayashi, J. Kamei, RhoA\/Rho kinase pathway contributes to the pathogenesis of thermal hyperalgesia in diabetic mice. Pain 152(1), 114\u2013122 (2011).","journal-title":"Pain"},{"issue":"1","key":"4227_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jaip.2023.09.015","volume":"12","author":"BG Kim","year":"2024","unstructured":"B.G. Kim, H. Lee, S.W. Yeom, C.Y. Jeong, D.W. Park, T.S. Park, J.Y. Moon, T.H. Kim, J.W. Sohn, H.J. Yoon, J.S. Kim, S.H. Kim, Increased risk of new-onset asthma after COVID-19: A nationwide population-based cohort study. J. Aller. Clin. Imm. -Pract. 12(1), 120\u2013132.e5 (2024).","journal-title":"J. Aller. Clin. Imm. -Pract."},{"issue":"1","key":"4227_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2022.2164215","volume":"12","author":"JH Hwang","year":"2023","unstructured":"J.H. Hwang, Y.S. You, S.W. Yeom, M.G. Lee, J.H. Lee, M.G. Kim, J.S. Kim, Influenza viral infection is a risk factor for severe illness in COVID-19 patients: A nationwide population-based cohort study. Emerg. Microbes Infect. 12(1), 2164215 (2023).","journal-title":"Emerg. Microbes Infect."},{"issue":"4","key":"4227_CR17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/jcpe.13753","volume":"50","author":"MG Kim","year":"2023","unstructured":"M.G. Kim, M.G. Kang, M.G. Lee, S.J. Yang, S.W. Yeom, J.H. Lee, S.M. Choi, J.H. Yoon, E.J. Lee, S.J. Noh, M.S. Kim, J.S. Kim, Periodontitis is associated with the development of fungal sinusitis: A nationwide 12-year follow-up study. J. Clin. Periodontol. 50(4), 440\u2013451 (2023).","journal-title":"J. Clin. Periodontol."},{"issue":"1","key":"4227_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","volume":"62","author":"JL Harding","year":"2019","unstructured":"J.L. Harding, M.E. Pavkov, D.J. Magliano, J.E. Shaw, E.W. Gregg, Global trends in diabetes complications: A review of current evidence. Diabetologia 62(1), 3\u201316 (2019).","journal-title":"Diabetologia"},{"issue":"3","key":"4227_CR19","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1080\/14737175.2022.2048649","volume":"22","author":"J Palomo-Osuna","year":"2022","unstructured":"J. Palomo-Osuna, H. De Sola, M. Duenas, J.A. Moral-Munoz, I. Failde, Cognitive function in diabetic persons with peripheral neuropathy: A systematic review and meta-analysis. Expert. Rev. Neurother. 22(3), 269\u2013281 (2022).","journal-title":"Expert. Rev. Neurother."},{"issue":"1","key":"4227_CR20","first-page":"41","volume":"54","author":"SM Timer","year":"2020","unstructured":"S.M. Timer, E. Timer, N.P. Y\u00fckselen, M.\u00c7 G\u00f6kyigit, The relationship between polyneuropathy and cognitive functions in type 2 diabetes mellitus patients. Med. B Sisli Etfal Ho 54(1), 41\u201346 (2020).","journal-title":"Med. B Sisli Etfal Ho"},{"issue":"4","key":"4227_CR21","doi-asserted-by":"publisher","first-page":"e420","DOI":"10.1002\/edm2.420","volume":"6","author":"SS Croosu","year":"2023","unstructured":"S.S. Croosu, M. Gjela, J. Roikjer, T.M. Hansen, C.D. Morch, J.B. Frokjaer, N. Ejskjaer, Cognitive function in individuals with and without painful and painless diabetic polyneuropathy-a cross- sectional study in type 1 diabetes. Endocrinol. Diabetes Metab. 6(4), e420 (2023).","journal-title":"Endocrinol. Diabetes Metab."},{"key":"4227_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-019-0359-2","volume":"19","author":"X Ding","year":"2019","unstructured":"X. Ding, C. Fang, X. Li, Y.J. Cao, Q.L. Zhang, Y. Huang, J. Pan, X. Zhang, Type 1 diabetes-associated cognitive impairment and diabetic peripheral neuropathy in Chinese adults: Results from a prospective cross-sectional study. BMC Endocr. Disord. 19, 34 (2019).","journal-title":"BMC Endocr. Disord."},{"issue":"2","key":"4227_CR23","doi-asserted-by":"publisher","first-page":"E25","DOI":"10.2337\/dci15-0028","volume":"39","author":"KA Nunley","year":"2016","unstructured":"K.A. Nunley, C.M. Ryan, J.A. Saxton, T. Costacou, T.J. Orchard, C. Rosano, Clinically relevant cognitive impairment in middle-aged adults with childhood-onset type 1 diabetes. Diabetes care 2015;38:1768-1776. Diabetes Care 39(2), E25\u2013E25 (2016).","journal-title":"Diabetes Care"},{"issue":"6","key":"4227_CR24","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S1474-4422(13)70112-1","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"J.M. Wardlaw, C. Smith, M. Dichgans, Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging (vol 12, pg 483, 2013). Lancet Neurol. 12(6), 532\u2013532 (2013).","journal-title":"Lancet Neurol."},{"key":"4227_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.595962","volume":"11","author":"DQ Wang","year":"2020","unstructured":"D.Q. Wang, L. Wang, M.M. Wei, X.S. Xia, X.L. Tian, X.H. Cui, X. Li, Relationship between type 2 diabetes and white matter hyperintensity: A systematic review. Front. Endocrinol. 11, 595962 (2020).","journal-title":"Front. Endocrinol."},{"key":"4227_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1084661","volume":"14","author":"C Lapucci","year":"2023","unstructured":"C. Lapucci, F. Tazza, S. Rebella, G. Boffa, E. Sbragia, N. Bruschi, E. Mancuso, N. Mavilio, A. Signori, L. Roccatagliata, M. Cellerino, S. Schiavi, M. Inglese, Central vein sign and diffusion MRI differentiate microstructural features within white matter lesions of multiple sclerosis patients with comorbidities. Front. Neurol. 14, 1084661 (2023).","journal-title":"Front. Neurol."},{"key":"4227_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1448225","volume":"15","author":"D Zhang","year":"2024","unstructured":"D. Zhang, Y. Huang, X. Zhang, W. Liu, Y. Guan, J. Gao, X. Lei, M. Tang, K. Ai, X. Yan, Potential effects of peripheral neuropathy on brain function in patients with type 2 diabetes mellitus. Front. Endocrinol. 15, 1448225 (2024).","journal-title":"Front. Endocrinol."},{"issue":"1","key":"4227_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.26563","volume":"45","author":"HT Xin","year":"2024","unstructured":"H.T. Xin, Y.J. Fu, H.W. Wen, M.M. Feng, C.F. Sui, Y. Gao, L.F. Guo, C.H. Liang, Cognition and motion dysfunction-associated brain functional network disruption in diabetic peripheral neuropathy. Hum. Brain Mapp. 45(1), e26563 (2024).","journal-title":"Hum. Brain Mapp."},{"issue":"6","key":"4227_CR29","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1210\/clinem\/dgab158","volume":"106","author":"F Fang","year":"2021","unstructured":"F. Fang, Q. Luo, R.B. Ge, M.Y. Lai, Y.J. Gong, M. Kang, M.M. Ma, L. Zhang, Y. Li, Y.F. Wang, Y.D. Peng, Decreased microstructural integrity of the central somatosensory tracts in diabetic peripheral neuropathy. J. Clin. Endocrinol. Metab. 106(6), 1566\u20131575 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"4227_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e18368","volume":"9","author":"YR Zang","year":"2023","unstructured":"Y.R. Zang, D.Q. Jiang, X.H. Zhuang, S.H. Chen, Changes in the central nervous system in diabetic neuropathy. Heliyon 9(8), e18368 (2023).","journal-title":"Heliyon"},{"key":"4227_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.747620","volume":"8","author":"JV Mui","year":"2021","unstructured":"J.V. Mui, J.D. Zhou, S. Lee, K.S.K. Leung, T.T.L. Lee, O.H.I. Chou, S.L. Tsang, A.K.C. Wai, T. Liu, W.T. Wong, C. Chang, G. Tse, Q.P. Zhang, Sodium-glucose cotransporter 2 (SGLT2) inhibitors vs. dipeptidyl peptidase-4 (DPP4) inhibitors for new-onset dementia: A propensity score-matched population-based study with competing risk analysis. Front. Cardiovasc. Med. 8, 747620 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"4227_CR32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12933-014-0148-1","volume":"13","author":"B Lin","year":"2014","unstructured":"B. Lin, N. Koibuchi, Y. Hasegawa, D. Sueta, K. Toyama, K. Uekawa, M. Ma, T. Nakagawa, H. Kusaka, S. Kim-Mitsuyama, Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice. Cardiovasc. Diabetol. 13, 148 (2014).","journal-title":"Cardiovasc. Diabetol."},{"key":"4227_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.taap.2017.08.005","volume":"333","author":"P Sa-Nguanmoo","year":"2017","unstructured":"P. Sa-Nguanmoo, P. Tanajak, S. Kerdphoo, T. Jaiwongkam, W. Pratchayasakul, N. Chattipakorn, S.C. Chattipakorn, SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats. Toxicol. Appl. Pharmacol. 333, 43\u201350 (2017).","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"4227_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11481-024-10140-y","volume":"19","author":"SM Khamies","year":"2024","unstructured":"S.M. Khamies, M.F. El-Yamany, S.M. Ibrahim, Canagliflozin mitigated cognitive impairment in streptozotocin-induced sporadic Alzheimer\u2019s disease in mice: role of AMPK\/SIRT-1 signaling pathway in modulating neuroinflammation. J. Neuroimmune Pharmacol. 19(1), 39 (2024).","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"6","key":"4227_CR35","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.3390\/neurolint16060124","volume":"16","author":"CH Hung","year":"2024","unstructured":"C.H. Hung, L.Y. Lu, New insights into the role of SGLT-2 inhibitors in the prevention of dementia. Neurol. Int. 16(6), 1717\u20131730 (2024).","journal-title":"Neurol. Int."},{"key":"4227_CR36","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.neubiorev.2016.03.005","volume":"64","author":"D Baglietto-Vargas","year":"2016","unstructured":"D. Baglietto-Vargas, J. Shi, D.M. Yaeger, R. Ager, F.M. LaFerla, Diabetes and Alzheimer\u2019s disease crosstalk. Neurosci. Biobehav. Rev. 64, 272\u2013287 (2016).","journal-title":"Neurosci. Biobehav. Rev."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04227-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04227-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04227-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T15:18:46Z","timestamp":1757171926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04227-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["4227"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04227-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5464066\/v1","asserted-by":"object"}]},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"16 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}